The global canine atopic dermatitis market size is expected to reach USD 1.8 billion by 2027, expanding at a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of the disease and growing companion ownership are the key factors driving the market growth.
Also, according to recent studies by The American Pet Products Association in 2018, veterinary care spending increased by 7% from USD 15.95 billion in 2016 to USD 17.07 billion in 2017. One of the leading causes for this rise is the growing concern among the owners about pet health due to rising pollution related health scares. Canine Atopic Dermatitis is one of them and causesscratching, itching, foul odor, loss of hair, scaly skin, etc., which causes hardships for the dogs.
Get Details For “Sample Report, TOC, Segmentation & methodology of Canine Atopic Dermatitis Market” Click Link Below:
An increase in the number of veterinary clinic visits is further boosting the canine atopic dermatitis market growth. According to the American Veterinary Medical Association (AVMA) report, as of 2018, around 70% dog owners usually go to veterinary hospitals or clinics for the routine check-up of their pets. These reasons are furling the market growth and are expected to continue pushing it further ahead. Several products are being promoted and used by the pet owners, which are proving their worth in the pet health area. These products are:
With the spread of COVID-19 and its anticipated origin being an animal, animal healthcare and treatment has taken centerstage. It has been able to push market growth in several countries, resulted from the rise in health concerns for animal.
Would you Like to Take a Look On “Sample Report” of Canine Atopic Dermatitis Market Click the Link Below:
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/7102/ibb
Further key findings from the report suggest:
On the basis of product, the Monoclonal Antibodies (MAbs) segment is projected to register a CAGR of 16.1% over the forecast period owing to increased efficacy and strong product pipeline
Based on mode of administration, the oral segment held the largest share as of 2019 owing to low cost and ease of administration
On the basis of distribution channel, the retail segment held the largest share as of 2019, owing to ever rising footprint of retail pharmacies and product availability
By region, Asia Pacific is expected to exhibit the highest growth rate over the forecast period due to increase in disposable income and growing companion ownership
Major Market Players:
Some Recent Market Developments
In March 2020, Merck Animal Health and Virbac announced that the companies have signed a definitive agreement under which Merck Animal Health would acquire the U.S. rights to SENTINEL FLAVOR TABS and SENTINEL SPECTRUM Chews in the Companion Animal category. Comprehensive parasite protection is an essential part of canine overall health and well-being. These complementary products will cover the seven common, harmful parasites that affect dogs inside and out by preventing ticks and multiple stages of the flea lifecycle, including eggs and adult fleas, as well as treating and controlling all common intestinal parasites, including roundworms, hookworms, whipworms and tapeworms and preventing heartworm disease. This will definitely help vets and owners to manage canine atopic dermatitis.
In 2018, Zoetis announced that U.S. Department of Agriculture (USDA) has granted an expanded indication for Cytopoint, a monoclonal antibody (mAb) therapy for the treatment of allergic dermatitis in dogs. Administered every four to eight weeks, one injection of Cytopoint works by targeting and neutralizing interleukin-31 (IL-31), a key protein involved in triggering itch in dogs, offering both convenience and sustained efficacy.
In 2019, Elanco Animal Health announced that it has signed an agreement to acquire Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. This will bring in larger expertise along with deep approach in more regions, helping Elanco to grow and expand quickly.
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 126 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 4126 analysts and consultants, the company adds 121200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 600 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States